Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT02595957 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Genomic Services Research Program

StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 71 years later Dec 31, 2028 → Dec 31, 2099
See other at-risk trials from National Human Genome Research Institute (NHGRI)

Record History

The 50 most recent of 387 record versions are accounted for below. See every version on ClinicalTrials.gov ↗

  1. Minor Re-verified, no change to tracked fields
  2. Minor Eligibility criteria expanded, about 4 words
  3. Notable Primary and study completion pushed from Dec 31, 2028 to Dec 31, 2099v385
  4. Minor 28 versions Re-verified since Dec 3, 2025, no change to tracked fieldsv357-v384
  5. Minor Study Status, Study Description, Eligibilityv356
  6. Minor 18 versions Re-verified since May 17, 2025, no change to tracked fieldsv338-v355
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Background: Genes are the instructions a person s body uses to function. Genome sequencing reads through all of a person s genes. Everyone has many gene variants, and most do not cause disease. Some gene variants called secondary findings may be important for a person s health even if they are not related to the reason why a person had genome sequencing done. Researchers want to learn more about what it means to have a secondary finding. Objectives: To learn about how gene variants may affect a person s health. To learn about how people understand their genetic test results. Eligibility: People with secondary findings from genetic testing done as part of a research study, clinical care, or other methods. Design: Participants may be asked to do an online survey and phone interview to ask what they think about their results, their healthcare, and if they talk with their family about the result. Eligible participants may be offered a visit to the NIH Clinical Center where they will be evaluated for health problems related to the secondary finding. DNA samples that were already collected may be studied. Participants may be asked to send in a second DNA sample (blood or saliva). These will be used to verify any findings. Participants who have a secondary finding can get genetic counseling.
Trial Details
NCT Number NCT02595957
Lead Sponsor National Human Genome Research Institute (NHGRI)
Conditions Colon Cancer, Breast Cancer
Enrollment 5,000 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov